28
Oct
2025

Lodaat Pharma

Exhibitor at CPHI Frankfurt 2025 stand 9.2B2, Integrated Pharma
About Us

LODAAT Pharma is a USA firm with a portfolio of innovative high value molecules including Biosimilars, Biologics, Rare Disease, Orphan Drugs. Our consumer health group is renowned for innovation in OTC in all major therapeutic categories including pain management, inflammation and gut microbiome.  We are a leading investor in NCE and new drug development for oncology, cognition, cardiovascular, and other therapeutic areas.  

We look for leading global partners who want to expand their portfolio and have a shared vision for cutting-edge therapeutics. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • US
  • 2015
    On CPHI since
  • 4
    Certificates
  • 100 - 249
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Biopharmaceutical
Nutraceuticals
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 9.2B2, Integrated Pharma

Products Featured at CPHI Frankfurt 2025

  • RARE DISEASES & ORPHAN DRUGS

    Product RARE DISEASES & ORPHAN DRUGS

    Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products.  USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets.  Many products are made in USA products in FDA approved facilities.
  • Biosimilars, and High Value Molecules

    Product Biosimilars, and High Value Molecules

    Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules.  We are looking for reputable global partners who want to expand their product line and in-license for their territory.
  • USFDA Oral Solid Dosages

    Product USFDA Oral Solid Dosages

    USFDA Oral Solid Dosages in major Therapeutic categories.  All products are USFDA registered and available in either Zone II or Zone IV stability studies.  Full dossiers available in either ECTD or CTD formats
  • EU GMP Oral Solid Dosage List

    Product EU GMP Oral Solid Dosage List

    LODAAT's Oral Solid Dosages are EU-GMP facility approved and are available in innovations such as ODT, Sachets, and Extended Release.  Our facilities handle all testing, production and full packaging capabilities.
  • Vitamins & OTC products- USA made

    Product Vitamins & OTC products- USA made

    LODAAT produces the best quality USA made Vitamins, Herbal supplements, Minerals and OTC products.  Our finished formulations are available in Tablets and Capsules.  We have 3 US facilities producing Private Label and Branded goods in Bottles and Blister packaging.  Best selling products inc...
  • INVIMA Approved Oncology

    Product INVIMA Approved Oncology

    Lodaat's Oncology Colombian INVIMA approved injectables with CTD dossier